⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4549129 | 0.67 | — | — | |
| SCHEMBL4969030 | 0.67 | — | — | |
| SCHEMBL4969038 | 0.67 | — | — | |
| SCHEMBL19072924 | 0.65 | — | — | |
| SCHEMBL19624067 | 0.65 | — | — | |
| SCHEMBL5489375 | 0.64 | — | — | |
| SCHEMBL28433 | 0.64 | — | — | |
| SCHEMBL5489373 | 0.64 | — | — | |
| SCHEMBL21746096 | 0.64 | — | — | |
| SCHEMBL26779 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0472526-B1 | 5-AMINOCARBONYL-5H-DIBENZO a,d]CYCLOHEPTEN-5,10-IMINES FOR TREATMENT OF EPILEPSY AND COCAINE ADDICTION | US HEALTH (US) | 1996-05-08 | — | — | EP | claimed |
| EP-3820869-B1 | SPIROCHROMANE DERIVATIVES | RICHTER GEDEON NYRT (HU) | 2023-08-30 | — | — | EP | disclosed |
| US-20230219896-A1 | CANNABINOID RECEPTOR MEDIATING COMPOUNDS | THE USA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2023-07-13 | — | — | US | disclosed |
| WO-2021183555-A1 | OCULAR DRUG DEPOT FOR COMPLEMENT-MEDIATED DISORDERS | ACHILLION PHARMACEUTICALS, INC. (US) | 2021-09-16 | — | — | WO | disclosed |
| US-10935699-B2 | Shape memory assisted self-healing polymeric amorphous coatings | SYRACUSE UNIVERSITY (US) | 2021-03-02 | — | — | US | disclosed |
| US-10787419-B2 | Cannabinoid receptor mediating iminopyrazole compounds | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2020-09-29 | — | — | US | disclosed |
| US-10683270-B2 | Cannabinoid receptor mediating compounds | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2020-06-16 | — | — | US | disclosed |
| WO-2020012422-A1 | SPIROCHROMANE DERIVATIVES | RICHTER GEDEON NYRT. (HU) | 2020-01-16 | — | — | WO | disclosed |
| US-20190352268-A1 | CANNABINOID RECEPTOR MEDIATING COMPOUNDS | THE USA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES (US) | 2019-11-21 | — | — | US | disclosed |
| US-9938301-B2 | Dihydropyrimido fused ring derivative as HBV inhibitor | QILU PHARMACEUTICAL CO., LTD. (CN) | 2018-04-10 | — | — | US | disclosed |
| US-5686614-A | Preparation of chiral 5-aminocarbonyl-5H-dibenzo a,d!cyclohepten-5,10-imines by optical resolution | NEUROGEN CORPORATION (US) | 1997-11-11 | — | — | US | disclosed |
| WO-1996032390-A1 | PREPARATION OF CHIRAL 5-AMINOCARBONYL-5H-DIBENZO-[a,d]CYCLOHEPTEN-5,10-IMINES BY OPTICAL RESOLUTION | NEUROGEN CORPORATION (US) | 1996-10-17 | — | — | WO | disclosed |
| EP-0472526-B1 | 5-AMINOCARBONYL-5H-DIBENZO a,d]CYCLOHEPTEN-5,10-IMINES FOR TREATMENT OF EPILEPSY AND COCAINE ADDICTION | US HEALTH (US) | 1996-05-08 | — | — | EP | disclosed |
| US-5196415-A | 5-aminocarbonyl-5H-dibenzo[a.d]cyclohepten-5,10-imines for treatment of epilepsy and cocaine addiction | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1993-03-23 | — | — | US | disclosed |
| WO-1992019108-A1 | TREATMENT OF ALCOHOL WITHDRAWAL SYMPTOMS | NATIONAL INSTITUTES OF HEALTH (US) | 1992-11-12 | — | — | WO | disclosed |
| EP-0472526-A4 | 5-AMINOCARBONYL-5H-DIBENZO A,D)CYCLOHEPTEN-5,10-IMINES FOR TREATMENT OF EPILEPSY AND COCAINE ADDICTION | US HEALTH (US) | 1992-05-20 | — | — | EP | disclosed |
| EP-0472526-A1 | 5-AMINOCARBONYL-5H-DIBENZO a,d]CYCLOHEPTEN-5,10-IMINES FOR TREATMENT OF EPILEPSY AND COCAINE ADDICTION. | US HEALTH (US) | 1992-03-04 | — | — | EP | disclosed |
| WO-1990013297-A1 | 5-AMINOCARBONYL-5H-DIBENZO[a,d]CYCLOHEPTEN-5,10-IMINES FOR TREATMENT OF EPILEPSY AND COCAINE ADDICTION | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, U.S. DEPARTMENT OF COMMERCE (US) | 1990-11-15 | — | — | WO | disclosed |
| US-4835164-A | HYPOTENSIVE AGENTS | A. H. ROBINS COMPANY, INCORPORATED (US) | 1989-05-30 | — | — | US | disclosed |
| EP-0279707-A2 | Aryloxymethyl derivatives of nitrogenous heterocyclic methanols and ethers thereof having cardiovascular activity | A.H. ROBINS COMPANY, INCORPORATED (US) | 1988-08-24 | — | — | EP | disclosed |